Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPTA
3201
Perpetua Resources
PPTA
$2.16B
| $415K | ﹤0.01% |
+56,806
| New | +$445K |
|
|
CVAC
3202
DELISTED
CureVac
CVAC
| $410K | ﹤0.01% |
+5,573
| New | +$557K |
|
3203
Exagen
XGN
$105M
| $406K | ﹤0.01% |
27,074
+16,821
| +164% | +$258K |
|
|
GORV
3204
DELISTED
Lazydays
GORV
| $402K | ﹤0.01% |
+608
| New | +$414K |
|
3205
Hamilton Beach Brands
HBB
$313M
| $397K | ﹤0.01% |
17,791
-3,788
| -18% | -$82.7K |
|
3206
Capital Bancorp
CBNK
$616M
| $394K | ﹤0.01% |
19,241
-27
| -0.1% | -$576 |
|
3207
Fathom Holdings
FTHM
$26.4M
| $390K | ﹤0.01% |
11,869
| – | – |
|
3208
Smith & Nephew
SNN
$13.7B
| $385K | ﹤0.01% |
8,858
-926
| -9% | -$39K |
|
3209
TSMC
TSM
$1.94T
| $385K | ﹤0.01% |
3,201
+281
| +10% | +$32.9K |
|
3210
Fresenius Medical Care
FMS
$13.4B
| $377K | ﹤0.01% |
9,069
-1,151
| -11% | -$46K |
|
3211
Crawford & Co Class B
CRD.B
$507M
| $376K | ﹤0.01% |
43,657
-3,047
| -7% | -$28.6K |
|
3212
ASML
ASML
$596B
| $375K | ﹤0.01% |
543
-108
| -17% | -$71.2K |
|
|
AFCG
3213
AFC Gamma
AFCG
$60.9M
| $373K | ﹤0.01% |
+26,368
| New | +$407K |
|
3214
Philips
PHG
$25.5B
| $366K | ﹤0.01% |
8,904
+745
| +9% | +$34.4K |
|
|
SMED
3215
DELISTED
Sharps Compliance Corp
SMED
| $363K | ﹤0.01% |
35,240
| – | – |
|
3216
Paysafe
PSFE
$443M
| $360K | ﹤0.01% |
+2,471
| New | +$371K |
|
3217
Summit Therapeutics
SMMT
$10.2B
| $356K | ﹤0.01% |
+47,648
| New | +$313K |
|
|
CORR
3218
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $354K | ﹤0.01% |
53,407
-34,077
| -39% | -$218K |
|
3219
Verrica Pharmaceuticals
VRCA
$89M
| $352K | ﹤0.01% |
3,112
| – | – |
|
3220
Arq
ARQ
$83.3M
| $351K | ﹤0.01% |
47,278
+6,671
| +16% | +$41.1K |
|
3221
Banco Santander
SAN
$191B
| $350K | ﹤0.01% |
89,460
-20,577
| -19% | -$79.8K |
|
3222
Biomea Fusion
BMEA
$88.2M
| $343K | ﹤0.01% |
+21,940
| New | +$387K |
|
|
SNCR
3223
DELISTED
Synchronoss Technologies
SNCR
| $334K | ﹤0.01% |
10,323
-17,003
| -62% | -$478K |
|
3224
Valhi
VHI
$389M
| $332K | ﹤0.01% |
+13,632
| New | +$353K |
|
3225
NLI Holdings
NL
$289M
| $331K | ﹤0.01% |
50,775
-5,230
| -9% | -$38.7K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.